Enlicitide
Overview
Enlicitide is an investigational peptide agonist designed to modulate metabolic pathways involved in energy balance and glucose homeostasis. Limited publicly available structural and mechanistic data suggest it may target incretin or related neuroendocrine pathways, though detailed receptor pharmacology has not been fully disclosed in the peer-reviewed literature.
Mechanism of Action
The compound is being explored for potential applications in obesity and metabolic disorders..
Research Summary & Key Findings
Preclinical studies have characterized pharmacokinetic profiles and receptor engagement, but detailed clinical trial results remain sparse in the published literature as of 2024. The development status and sponsoring organization have not widely publicized phase 2 or phase 3 outcomes, indicating the compound remains in early investigational stages.
Clinical Status
Enlicitide is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.
Administration Routes
Related Peptides in Metabolic
Semaglutide (Ozempic/Wegovy)
FDA ApprovedA glucagon-like peptide-1 receptor agonist (GLP-1 RA) with 94% amino acid homology to native GLP-1. Semaglutide enhances...
View detailsTirzepatide (Mounjaro/Zepbound)
FDA ApprovedA first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide activat...
View detailsRetatrutide
In Clinical TrialsAn investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The gluc...
View detailsAOD-9604
InvestigationalA modified 16-amino acid fragment (amino acids 176-191) of the C-terminus of human growth hormone with an added tyrosine...
View detailsFind a Provider
Find a verified provider who offers Enlicitide therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Enlicitide.
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.